Delivery Order SPE2DB20D3101-SPE2DB24FRDQ3
- Not listed
- This federal contract award, valued at $1,554.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order (DO) to provide LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the DLA. The contract has a period of performance ending on February 6, 2024 and is a Firm Fixed Price (FFP) agreement. There is no set-aside designation for this award, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award, valued at $4,144.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed price type and covers the procurement of LIDOCAINE 5% PATCH 30S, a medical product. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award, valued at $2,299.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of 4558244987 – LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has a firm fixed price and ultimate completion date of August 29, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $2,135.27 and is a firm fixed-price delivery order for 4563004664 - LIDOCAINE 5% PATCH 30S. The award has an ultimate completion date of December 6, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,612.01 Firm Fixed Price Delivery Order is for the provision of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $14,614.74, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4554257218 - LIDOCAINE 5% PATCH 30S, a pharmaceutical product, with a completion date of July 29, 2021. This is a firm fixed-price delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award is a delivery order valued at $1,202.00 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The order is for 4559509218 - LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2023 and was awarded on January 5, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $1,769.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also a for-profit organization. The contract is a Delivery Order under an...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of a pharmaceutical product, specifically LIDOCAINE 5% PATCH 30S, with a ceiling value of $12,245.45. The contract was awarded on December 4, 2023, with a final completion date of December 5, 2023. This is a Delivery Order contract with a Firm Fixed Price pricing type. The contract does not...
- This federal contract award is for the delivery of 4556004056 - LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA). The contract, valued at $2,039.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 20, 2022. This is a firm fixed-price delivery order contract with an ultimate completion date of January 21, 2022. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRDQ3Delivery Order
This federal contract award, valued at $2,021.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4563941538 - LIDOCAINE 5% PATCH 30S, with a completion date of March 13, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 3/12/24 |